The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, has appointed an advisory board to guide its strategy. Providing insight and expertise from across the industry, the board consists of 12 senior individuals spread throughout Europe and the US. Members are drawn from leadership positions in a variety of global life science, pharmaceutical and technology businesses; along with governmental and public bodies, including NICE and the NHS. The board will meet for the first time in London in March 2017.
13 February, 2017
IBST/EEN Partnership Building EventWednesday 10 May 2017
13 February, 2017
Intelligent Fingerprinting, the UK company developing the world’s first portable fingerprint-based drug screening system, has secured a further £3 million of funding from an expanded group of private US and UK investors. The investment will support the early commercialisation of the first drug screening panel, and include manufacturing scale-up and validation of the company’s first products made at its dedicated facility in Cambridge. These products are to be used widely in pilot programmes within the UK and US.
11 February, 2017
Cancer Research UK today (Friday) announces that four international teams are the first recipients of its global £100m Grand Challenge competition, which aims to overcome the biggest challenges facing cancer researchers in a global effort to beat cancer sooner.
10 February, 2017